Home > News > Nano-Sized Bomb Targets Tumors
August 11th, 2005
Nano-Sized Bomb Targets Tumors
Traditional attempts to destroy cancerous tumors involve treatments such as chemotherapy that kill healthy cells right along with mutated ones, often leaving patients weak, nauseous, hairless and vulnerable to infection.
But now biologists and engineers at the Massachusetts Institute of Technology have engineered a dual-chamber molecular bomb designed to infiltrate a tumor, shut down its blood vessels — thereby sealing off the exits — and detonate a dose of cancer-killing toxins.
Superconducting circuits, simplified: New circuit design could unlock the power of experimental superconducting computer chips October 18th, 2014
Nanocoatings Market By Product Is Expected To Reach USD 8.17 Billion By 2020: Grand View Research, Inc. October 15th, 2014
Perpetuus Carbon Group Receives Independent Verification of its Production Capacity for Graphenes at 140 Tonnes per Annum: Perpetuus Becomes the First Manufacturer in the Sector to Allow Third Party Audit October 7th, 2014
PEN Inc. Chairman Scott Rickert Announces Company Vision, Product Priorities and Management Team: Webcast Highlights the Launch of PEN October 3rd, 2014
Non-Toxic Nanocatalysts Open New Window for Significant Decrease in Reaction Process October 19th, 2014
European Commission opens the gate towards the implementation of Nanomedicine Translation Hub October 16th, 2014
Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014
Tuning light to kill deep cancer tumors: Nanoparticles developed at UMass Medical School advance potential clinical application for photodynamic therapy October 15th, 2014